Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002349 · ClinicalTrials.gov registry record · NA
A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.
A NA study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00002349 is a NA study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 40 participants.
The verdict
NCT00002349, a NA study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
To compare the antiviral effect of stavudine ( d4T ) versus placebo in patients with evidence of recent HIV infection. Also, to compare the immunologic effects and effects on quality of life of d4T in these patients.
Interventions
- DRUG Stavudine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 1995-01 |
| Est. Completion | 1999-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002349
The ClinicalTrials.gov registry entry for NCT00002349 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stavudine is the first listed.
NCT00002349 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002349 about?
NCT00002349 is a clinical study titled "A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.". To compare the antiviral effect of stavudine ( d4T ) versus placebo in patients with evidence of recent HIV infection. Also, to compare the immunologic effects and effects on quality of life of d4T in these patients.
What is the current status of trial NCT00002349?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 1995-01. Estimated completion is 1999-05.
What interventions are being tested in trial NCT00002349?
The interventions under investigation include: Stavudine (DRUG).
Who is sponsoring clinical trial NCT00002349?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.